Surveillance Imaging for Myxoid Liposarcoma: Contrast Requirements
For myxoid liposarcoma surveillance, you should obtain the abdominal and pelvic CT scan WITH contrast, and the spine MRI should ideally be performed as part of a whole-body MRI protocol WITHOUT and WITH contrast.
Rationale for Contrast Use
Abdominal and Pelvic CT Scan
The most recent UK guidelines (2025) specifically recommend that abdominal and pelvic CT scans should be performed routinely for myxoid liposarcoma due to the higher incidence of soft-tissue metastases in this histologic subtype 1. While the guidelines don't explicitly mandate contrast, standard oncologic imaging practice for metastatic surveillance requires contrast enhancement to:
- Detect soft-tissue metastases with adequate sensitivity
- Characterize solid organ involvement (liver, peritoneum)
- Assess lymph node morphology and enhancement patterns
The SELNET guidelines (2022) recommend abdominal and pelvic CT for myxoid liposarcoma staging 2, and standard CT protocols for oncologic surveillance universally employ IV contrast unless contraindicated.
Spine MRI - Consider Whole-Body MRI Instead
Here's where the evidence strongly diverges from traditional practice:
The 2022 SELNET guidelines explicitly state that "spine and pelvic MRI is preferred in myxoid liposarcoma" 2. However, the most compelling evidence suggests you should consider whole-body MRI rather than isolated spine MRI.
Why Whole-Body MRI is Superior:
The 2025 UK guidelines note that "whole body MRI can also be considered" as an alternative to CT for myxoid liposarcoma 1. More importantly, recent research demonstrates that:
- CT scan fails to detect the majority of bone metastases in myxoid liposarcoma - only 1 of 14 bone metastases showed sclerotic/blastic presentation visible on CT, while the remaining 13 required MRI for diagnosis 3
- Whole-body MRI detected metastases in 76.5% of patients that changed clinical management, with 33 instances of treatment modification 4
- WBMRI identified 29 soft-tissue or osseous metastases, of which only 5 soft-tissue and ZERO osseous metastases were detected on simultaneous CT scans 5
Specific Contrast Protocol Recommendations
For Spine/Whole-Body MRI:
Perform MRI WITHOUT and WITH IV contrast 2. The rationale:
- Without contrast sequences (including DWI/ADC) help detect small metastatic foci and provide baseline tissue characterization
- With contrast sequences increase conspicuity of small lesions and help characterize indeterminate findings
- The 2022 SELNET guidelines specifically recommend brain MRI for certain sarcomas "without and with IV contrast" 2, and this principle extends to spine/whole-body imaging
For Abdominal/Pelvic CT:
Use multiphase contrast-enhanced CT - this is the standard for oncologic surveillance and metastatic detection, though the guidelines don't explicitly specify the protocol details for myxoid liposarcoma surveillance.
Critical Pitfalls to Avoid
Don't rely solely on chest CT for surveillance - myxoid liposarcoma has a propensity for extrapulmonary metastases (soft tissue 84%, bone 45%, intraabdominal 48%) 3
Don't use bone scan for bone metastases - it will miss the vast majority of myxoid liposarcoma bone metastases, which are typically non-sclerotic 3
Don't limit spine imaging to isolated spine MRI - consider whole-body MRI to capture the diverse metastatic pattern (retroperitoneum 29%, other soft tissues 22%, bone 15%) 6
Don't stop surveillance at 5 years - 8.9% of patients developed their first metastasis more than 5 years after primary diagnosis 4
Practical Algorithm
Optimal surveillance protocol for myxoid liposarcoma:
- Chest CT (with or without contrast - for pulmonary metastases)
- Abdomen/pelvis CT WITH contrast (for visceral and soft-tissue metastases)
- Whole-body MRI without and with contrast (superior to isolated spine MRI for detecting bone and soft-tissue metastases)
If whole-body MRI is not available:
- Spine MRI without and with contrast as you planned
- Recognize this is suboptimal and may miss extrapulmonary disease
The evidence strongly suggests that whole-body MRI should be the standard for myxoid liposarcoma surveillance given its unique metastatic pattern 3, 4, 5.